NVCR (STOCKS)
NovoCure Limited Ordinary Shares
$17.008200
-0.581800 (-3.31%)
Prev close: $17.590000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Frank Leonard
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,325.04M
- Employees
- 1,488
- P/E (TTM)
- -13.43
- P/B (TTM)
- 6.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.17 | $-0.34 | +0.1681 | +49.72% |
|
Mar 2026 (Q1)
|
$-0.62 | $-0.52 | -0.0969 | -18.52% |
|
Dec 2025 (Q4)
|
$-0.22 | $-0.42 | +0.1997 | +47.58% |
|
Sep 2025 (Q3)
|
$-0.33 | $-0.43 | +0.0994 | +23.15% |
Financial Statements
| Revenues | $699.19M |
| Benefits Costs and Expenses | $851.88M |
| Cost Of Revenue | $166.92M |
| Costs And Expenses | $851.88M |
| Gross Profit | $532.27M |
| Operating Expenses | $686.67M |
| Depreciation and Amortization | $16.31M |
| Research and Development | $224.72M |
| Other Operating Expenses | $445.64M |
| Operating Income/Loss | -$154.40M |
| Income/Loss From Continuing Operations After Tax | -$148.57M |
| Income/Loss From Continuing Operations Before Tax | -$152.69M |
| Income Tax Expense/Benefit | -$4.12M |
| Net Income/Loss | -$148.57M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$148.57M |
| Net Income/Loss Available To Common Stockholders, Basic | -$148.57M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.30 |
| Diluted Earnings Per Share | -$1.30 |
| Basic Average Shares | 227,227,561 |
| Diluted Average Shares | 227,227,561 |
| Assets | $795.19M |
| Current Assets | $638.52M |
| Inventory | $42.22M |
| Other Current Assets | $596.30M |
| Noncurrent Assets | $156.67M |
| Fixed Assets | $75.37M |
| Other Non-current Assets | $81.30M |
| Liabilities | $457.10M |
| Current Liabilities | $220.71M |
| Noncurrent Liabilities | $236.39M |
| Equity | $338.09M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $338.09M |
| Liabilities And Equity | $795.19M |
| Net Cash Flow From Operating Activities | -$2.82M |
| Net Cash Flow From Operating Activities, Continuing | -$2.82M |
| Net Cash Flow From Investing Activities | $409.13M |
| Net Cash Flow From Investing Activities, Continuing | $409.13M |
| Net Cash Flow From Financing Activities | -$454.60M |
| Net Cash Flow From Financing Activities, Continuing | -$454.60M |
| Exchange Gains/Losses | -$236.00K |
| Net Cash Flow | -$48.52M |
| Net Cash Flow, Continuing | -$48.28M |
| Comprehensive Income/Loss | -$146.88M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$146.88M |
| Other Comprehensive Income/Loss | $26.62M |